Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_1	Adenovirus	oAd/DCN/LRP	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	PANC-1	Grown to 70% confluence	NA	MTT assay	50 MOI	59% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	IL-6 production increased by 3 folds as compared to normal	NA	26471393
OV_2	Adenovirus	oAd/DCN/LRP	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	PANC-1	Grown to 70% confluence	NA	MTT assay	100 MOI	56% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	IL-6 production increased by 3 folds as compared to normal	NA	26471393
OV_3	Adenovirus	oAd/DCN/LRP	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	PANC-1	Grown to 70% confluence	NA	MTT assay	200 MOI	49% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	IL-6 production increased by 3 folds as compared to normal	NA	26471393
OV_4	Adenovirus	oAd/DCN/LRP-PEG	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	PANC-1	Grown to 70% confluence	NA	MTT assay	50 MOI	90% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_5	Adenovirus	oAd/DCN/LRP-PEG	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	PANC-1	Grown to 70% confluence	NA	MTT assay	100 MOI	78% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_6	Adenovirus	oAd/DCN/LRP-PEG	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	PANC-1	Grown to 70% confluence	NA	MTT assay	200 MOI	78% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_7	Adenovirus	oAd/DCN/LRP-PEG-NT	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	PANC-1	Grown to 70% confluence	NA	MTT assay	50 MOI	70% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_8	Adenovirus	oAd/DCN/LRP-PEG-NT	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	PANC-1	Grown to 70% confluence	NA	MTT assay	100 MOI	60% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_9	Adenovirus	oAd/DCN/LRP-PEG-NT	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	PANC-1	Grown to 70% confluence	NA	MTT assay	200 MOI	38% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_10	Adenovirus	oAd/DCN/LRP	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIAPaCa-2	Grown to 70% confluence	NA	MTT assay	10 MOI	70% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	IL-6 production increased by 3 folds as compared to normal	NA	26471393
OV_11	Adenovirus	oAd/DCN/LRP	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIAPaCa-2	Grown to 70% confluence	NA	MTT assay	50 MOI	58% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	IL-6 production increased by 3 folds as compared to normal	NA	26471393
OV_12	Adenovirus	oAd/DCN/LRP	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIAPaCa-2	Grown to 70% confluence	NA	MTT assay	100 MOI	38% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	IL-6 production increased by 3 folds as compared to normal	NA	26471393
OV_13	Adenovirus	oAd/DCN/LRP-PEG	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIAPaCa-2	Grown to 70% confluence	NA	MTT assay	10 MOI	100% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_14	Adenovirus	oAd/DCN/LRP-PEG	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIAPaCa-2	Grown to 70% confluence	NA	MTT assay	50 MOI	95% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_15	Adenovirus	oAd/DCN/LRP-PEG	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIAPaCa-2	Grown to 70% confluence	NA	MTT assay	100 MOI	94% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_16	Adenovirus	oAd/DCN/LRP-PEG-NT	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIAPaCa-2	Grown to 70% confluence	NA	MTT assay	10 MOI	77% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_17	Adenovirus	oAd/DCN/LRP-PEG-NT	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIAPaCa-2	Grown to 70% confluence	NA	MTT assay	50 MOI	72% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_18	Adenovirus	oAd/DCN/LRP-PEG-NT	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIAPaCa-2	Grown to 70% confluence	NA	MTT assay	100 MOI	58% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_28	Adenovirus	oAd/DCN/LRP	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	AsPC-1	Grown to 70% confluence	NA	MTT assay	5 MOI	80% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	IL-6 production increased by 3 folds as compared to normal	NA	26471393
OV_29	Adenovirus	oAd/DCN/LRP	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	AsPC-1	Grown to 70% confluence	NA	MTT assay	10 MOI	78% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	IL-6 production increased by 3 folds as compared to normal	NA	26471393
OV_30	Adenovirus	oAd/DCN/LRP	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	AsPC-1	Grown to 70% confluence	NA	MTT assay	20 MOI	40% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	IL-6 production increased by 3 folds as compared to normal	NA	26471393
OV_31	Adenovirus	oAd/DCN/LRP-PEG	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	AsPC-1	Grown to 70% confluence	NA	MTT assay	5 MOI	90% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_32	Adenovirus	oAd/DCN/LRP-PEG	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	AsPC-1	Grown to 70% confluence	NA	MTT assay	10 MOI	82% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_33	Adenovirus	oAd/DCN/LRP-PEG	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	AsPC-1	Grown to 70% confluence	NA	MTT assay	20 MOI	84% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_34	Adenovirus	oAd/DCN/LRP-PEG-NT	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	AsPC-1	Grown to 70% confluence	NA	MTT assay	5 MOI	89% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_35	Adenovirus	oAd/DCN/LRP-PEG-NT	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	AsPC-1	Grown to 70% confluence	NA	MTT assay	10 MOI	94% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_36	Adenovirus	oAd/DCN/LRP-PEG-NT	DNA	Adenoviridae	Insertional mutant for DCN and LRP gene with NT-conjugated polyethylene glycol	Yes	No	No	ATCC	Human pancreatic cancer cell line	AsPC-1	Grown to 70% confluence	NA	MTT assay	20 MOI	94% cancer cell viability	No	No	NA	No response	NA	Inhibits Wnt/Î²-catenin and TGF-Î²1 signaling pathways	NA	NA	26471393
OV_582	Alphavirus	M1	RNA	Togaviridae	None	No	Viral strain in combination with H89(10 Î¼M) for 1 hour	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Very small toxicity towards human immortalized liver cell line L-02	MTT assay	0.001 PFU/cell	86% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	JNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activated	M1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89	NA	27374176
OV_583	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Non toxic to human immortalized liver cell line L-02	MTT assay	0.001 PFU/cell	100% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	NA	M1 upregulated transcriptional ISGs (329 shown here)	NA	27374176
OV_584	Alphavirus	M1	RNA	Togaviridae	None	No	Viral strain in combination with H89(10 Î¼M) for 1 hour	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Very small toxicity towards human immortalized liver cell line L-02	MTT assay	0.01 PFU/cell	80% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	JNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activated	M1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89	NA	27374176
OV_585	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Non toxic to human immortalized liver cell line L-02	MTT assay	0.01 PFU/cell	100% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	NA	M1 upregulated transcriptional ISGs (329 shown here)	NA	27374176
OV_586	Alphavirus	M1	RNA	Togaviridae	None	No	Viral strain in combination with H89(10 Î¼M) for 1 hour	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Very small toxicity towards human immortalized liver cell line L-02	MTT assay	0.1 PFU/cell	70% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	JNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activated	M1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89	NA	27374176
OV_587	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Non toxic to human immortalized liver cell line L-02	MTT assay	0.1 PFU/cell	100% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	NA	M1 upregulated transcriptional ISGs (329 shown here)	NA	27374176
OV_588	Alphavirus	M1	RNA	Togaviridae	None	No	Viral strain in combination with H89(10 Î¼M) for 1 hour	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Very small toxicity towards human immortalized liver cell line L-02	MTT assay	1 PFU/cell	38% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	JNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activated	M1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89	NA	27374176
OV_589	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Non toxic to human immortalized liver cell line L-02	MTT assay	1 PFU/cell	90% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	NA	M1 upregulated transcriptional ISGs (329 shown here)	NA	27374176
OV_590	Alphavirus	M1	RNA	Togaviridae	None	No	Viral strain in combination with H89(10 Î¼M) for 1 hour	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Very small toxicity towards human immortalized liver cell line L-02	MTT assay	10 PFU/cell	25% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	JNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activated	M1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89	NA	27374176
OV_591	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	Non toxic to human immortalized liver cell line L-02	MTT assay	10 PFU/cell	80% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	NA	M1 upregulated transcriptional ISGs (329 shown here)	NA	27374176
OV_600	Alphavirus	M1	RNA	Togaviridae	None	No	Viral strain in combination with ESI-09 and with H89(10 Î¼M)	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	NA	MTT assay	0.1 PFU/cell	75% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	ESI-09 abrogates the activities of Caspase-3/9/8 induced by H89/M1 combination treatment.	M1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89	NA	27374176
OV_601	Alphavirus	M1	RNA	Togaviridae	None	No	Viral strain in combination with ESI-09	No	ATCC	Human pancreatic ductal adenocarcinoma cell line	Capan-1	4000 cells per well	NA	MTT assay	0.1 PFU/cell	82% cancer cell viability at 72 hours post-infection	No	No	NA	No response	NA	ESI-09 abrogates the activities of Caspase-3/9/8 induced by H89/M1 combination treatment.	M1 upregulated transcriptional ISGs (329 shown here)	NA	27374176
OV_717	Avian influenza A virus	H7N3 NS1-77	RNA	Orthomyxoviridae	Mutations were introduced within the IAV NS1 gene to create a truncated protein of 77 aa (NS1-77)	Yes	No	No	NA	Human pancreatic cancer cell line	BxPC-3	NA	NA	Immunoassay detection	0.001 MOI	130% cancer cell death (calculated as relative to mock-infected)	No	No	NA	No response	NA	NA	Up-regulation of IFN-aplha	NA	27417501
OV_718	Avian influenza A virus	H7N3 NS1-77	RNA	Orthomyxoviridae	Mutations were introduced within the IAV NS1 gene to create a truncated protein of 77 aa (NS1-77)	Yes	No	No	NA	Human pancreatic cancer cell line	MIAPaCa-2	NA	NA	Immunoassay detection	0.001 MOI	70% cancer cell death (calculated as relative to mock-infected)	No	No	NA	No response	NA	NA	Up-regulation of IFN-aplha	NA	27417501
OV_719	Avian influenza A virus	H7N3 NS1-77	RNA	Orthomyxoviridae	Mutations were introduced within the IAV NS1 gene to create a truncated protein of 77 aa (NS1-77)	Yes	No	No	NA	Human caucasian pancreatic adenocarcinoma	CFPAC-1	NA	NA	Immunoassay detection	0.001 MOI	111% cancer cell death (calculated as relative to mock-infected)	No	No	NA	No response	NA	NA	Up-regulation of IFN-aplha	NA	27417501
OV_720	Avian influenza A virus	H7N3 NS1-77	RNA	Orthomyxoviridae	Mutations were introduced within the IAV NS1 gene to create a truncated protein of 77 aa (NS1-77)	Yes	No	No	NA	Human pancreas adenocarcinoma cell line	AsPC-1	NA	NA	Immunoassay detection	0.001 MOI	128% cancer cell death (calculated as relative to mock-infected)	No	No	NA	No response	NA	NA	Up-regulation of IFN-aplha	NA	27417501
OV_721	Avian influenza A virus	H7N3	RNA	Orthomyxoviridae	None	Yes	No	No	NA	Human pancreatic cancer cell line	BxPC-3	NA	NA	Immunoassay detection	0.001 MOI	148% cancer cell death (calculated as relative to mock-infected)	No	No	NA	No response	NA	NA	Up-regulation of IFN-aplha	NA	27417501
OV_722	Avian influenza A virus	H7N3	RNA	Orthomyxoviridae	None	Yes	No	No	NA	Human pancreatic cancer cell line	MIAPaCa-2	NA	NA	Immunoassay detection	0.001 MOI	90% cancer cell death (calculated as relative to mock-infected)	No	No	NA	No response	NA	NA	Up-regulation of IFN-aplha	NA	27417501
OV_723	Avian influenza A virus	H7N3	RNA	Orthomyxoviridae	None	Yes	No	No	NA	Human caucasian pancreatic adenocarcinoma	CFPAC-1	NA	NA	Immunoassay detection	0.001 MOI	130% cancer cell death (calculated as relative to mock-infected)	No	No	NA	No response	NA	NA	Up-regulation of IFN-aplha	NA	27417501
OV_724	Avian influenza A virus	H7N3	RNA	Orthomyxoviridae	None	Yes	No	No	NA	Human pancreas adenocarcinoma cell line	AsPC-1	NA	NA	Immunoassay detection	0.001 MOI	165% cancer cell death (calculated as relative to mock-infected)	No	No	NA	No response	NA	NA	Up-regulation of IFN-aplha	NA	27417501
OV_1406	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with norfloxacin (12.5 microgram/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.5 MOI	70% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1407	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with norfloxacin (12.5 microgram/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	35% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1408	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with norfloxacin (25 microgram/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	BxPC-3	NA	NA	MTT assay	0.5 MOI	70% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1409	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with norfloxacin (25 microgram/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	BxPC-3	NA	NA	MTT assay	1 MOI	30% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1410	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (6.25pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.1 MOI	70% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1411	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (6.25pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	70% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1412	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (6.25pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	10 MOI	60% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1413	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (12.5pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.1 MOI	70% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1414	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (12.5pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	70% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1415	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (12.5pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	10 MOI	65% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1416	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (25pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.1 MOI	70% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1417	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (25pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	70% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1418	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (25pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	10 MOI	65% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1419	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (50pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.1 MOI	50% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1420	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (50pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	50% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1421	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (50pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	10 MOI	45% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1422	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (100pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.1 MOI	30% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1423	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (100pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	30% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1424	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (100pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	10 MOI	20% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1425	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (12.5pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.1 MOI	42% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1426	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (12.5pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	42% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1427	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (12.5pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	10 MOI	40% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1428	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (25pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.1 MOI	20% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1429	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (25pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	20% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1430	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (25pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	10 MOI	10% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1431	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (50pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.1 MOI	10% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1432	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (50pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	10% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1433	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (50pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	10 MOI	10% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1434	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (100pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	0.1 MOI	10% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1435	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (100pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	1 MOI	10% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1436	Parovirus	H-1PV	DNA	Paroviridae	None	No	Virus strain in combination with reservatol (100pg/ml)	No	ATCC	Human pancreatic adenocarcinoma cell line	PANC-1	NA	NA	MTT assay	10 MOI	10% cell survival	No	No	NA	No response	NA	Induction of apoptosis, activation of caspase 3	NA	NA	19301953
OV_1842	Herpes simplex virus	NV1023	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.01 MOI	100% cell survival after day 1	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1843	Herpes simplex virus	NV1024	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.01 MOI	100% cell survival after day 3	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1844	Herpes simplex virus	NV1025	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.01 MOI	80% cell survival after day 5	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1845	Herpes simplex virus	NV1026	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.01 MOI	70% cell survival after day 7	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1846	Herpes simplex virus	NV1027	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	90% cell survival after day 1	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1847	Herpes simplex virus	NV1028	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	90% cell survival after day 3	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1848	Herpes simplex virus	NV1029	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	80% cell survival after day 5	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1849	Herpes simplex virus	NV1030	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	60% cell survival after day 7	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1850	Herpes simplex virus	NV1031	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	1 MOI	70% cell survival after day 1	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1851	Herpes simplex virus	NV1032	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	1 MOI	65% cell survival after day 3	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1852	Herpes simplex virus	NV1033	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	1 MOI	50% cell survival after day 5	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1853	Herpes simplex virus	NV1034	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	Hs766T	2.0E+4 cells per well	NA	LDH release assay	1 MOI	20% cell survival after day 7	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1854	Herpes simplex virus	NV1035	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	No cell killing after day 1	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1855	Herpes simplex virus	NV1036	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	No cell killing after day 3	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1856	Herpes simplex virus	NV1037	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	No cell killing after day 5	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1857	Herpes simplex virus	NV1038	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.1 MOI	No cell killing after day 7	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1858	Herpes simplex virus	NV1039	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.2 MOI	No cell killing after day 1	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1859	Herpes simplex virus	NV1040	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.2 MOI	No cell killing after day 3	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1860	Herpes simplex virus	NV1041	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.2 MOI	98% cell survival after day 5	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1861	Herpes simplex virus	NV1042	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.2 MOI	No cell killing after day 5	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1862	Herpes simplex virus	NV1043	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.4 MOI	No cell killing after day 1	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009
OV_1863	Herpes simplex virus	NV1044	DNA	Herpesviridae	Insertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 gene	Yes	No	No	ATCC	Human pancreatic cancer cell line	MIA paCa-2	2.0E+4 cells per well	NA	LDH release assay	0.4 MOI	No cell killing after day 3	No	No	NA	No response	NA	Induction of apoptosis by the virus	NA	NA	20629009

previous12 3 4 5 6 next